| ACSL4 | acyl-CoA synthetase long-chain family member 4 |
| ALT | alanine aminotransferase |
| AMPK | AMP-activated protein kinase |
| APC | antigen-presenting cell |
| AST | aspartate aminotransferase |
| AUC | area under the concentration-time curve |
| BA | bioavailability |
| BAX | BCL2-associated X protein |
| BCL2 | B-cell lymphoma 2 |
| BCS | Biopharmaceutics Classification System |
| CD206 | mannose receptor |
| CNS | central nervous system |
| Cmax | maximum plasma concentration |
| EC50 | half-maximal effective concentration |
| EPGLa | G. lucidum polysaccharide a |
| EPR | enhanced permeability and retention |
| GAA | ganoderic acid A |
| GAB | ganoderic acid B |
| GAC1 | ganoderic acid C1 |
| GAC2 | ganoderic acid C2 |
| GAD | ganoderic acid D |
| GAF | ganoderic acid F |
| GAG | ganoderic acid G |
| GAH | ganoderic acid H |
| GAK | ganoderic acid K |
| GALT | gut-associated lymphoid tissue |
| GA-NPs | ganoderic acid-loaded nanoparticles |
| GA-SLNs | ganoderic acid-loaded solid lipid nanoparticles |
| GL-AgNPs | G. lucidum-mediated silver nanoparticles |
| GLNs | G. lucidum-derived nanovesicles |
| GLP | G. lucidum polysaccharide |
| GLP-LNPs | GLP-loaded lipid nanoparticles |
| GLP-LU-TeNRs | GLP-based multifunctional tellurium nanorods |
| GLP-MTX | GLP-methotrexate conjugate |
| GLP-SeNPs | GLP-stabilized selenium nanoparticles |
| GMP | Good Manufacturing Practice |
| GSH-GPX4 | glutathione-glutathione peroxidase 4 |
| HO-1 | heme oxygenase-1 |
| HPLC | high-performance liquid chromatography |
| HWE | hot water extraction |
| IL-6 | interleukin-6 |
| JAK/STAT | Janus kinase/signal transducer and activator of transcription |
| LC-MS/MS | liquid chromatography-tandem mass spectrometry |
| LNP | lipid nanoparticle |
| MAE | microwave-assisted extraction |
| MAFLD | metabolic-associated fatty liver disease |
| MAPK | mitogen-activated protein kinase |
| MN-WSG | dissolvable microneedle patch loaded with water-soluble glucan |
| mRNA | messenger RNA |
| Mw | molecular weight |
| NF-κB | nuclear factor kappa-B |
| NLC | nanostructured lipid carrier |
| NO | nitric oxide |
| NP | nanoparticle |
| NRF2 | nuclear factor erythroid 2-related factor 2 |
| PK | pharmacokinetic |
| PLGA | poly(lactic-co-glycolic acid) |
| PNP | polymeric nanoparticle |
| RCT | randomized controlled trial |
| ROS | reactive oxygen species |
| SAF | structure–activity–formulation |
| SCE | supercritical CO2 extraction |
| SeNP | selenium nanoparticle |
| SLN | solid lipid nanoparticle |
| SOD | superoxide dismutase |
| t1/2 | elimination half-life |
| TeNR | tellurium nanorod |
| TLR4 | Toll-like receptor 4 |
| Tmax | time to maximum plasma concentration |
| TNF-α | tumor necrosis factor-alpha |
| UAE | ultrasonic-assisted extraction |
| UMAE | ultrasonic-microwave-assisted extraction |
| UPLC-Q-TOF/MS | ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry |
| WSG | water-soluble glucan |
| XRCC1 | X-ray repair cross-complementing protein 1 |